Whelton A
Prog Clin Biol Res. 1979;35:33-41.
In the presence of healthy renal tissues, aminoglycosides demonstrate important differences in quantitative renal cortical accumulation. These phenomena may correlate with clinical toxicity. Proximal tubular reabsorptive pathways appear to be of key significance in the production of high renal cortical drug concentrations. It appears that such drug transport can be blocked competitively. The presence of severe disease in renal tissues significantly influences the intrarenal distribution characteristics of antibiotics and is associated with reduced parenchymal concentration of all drugs, with the exception of doxycycline. Studies defining the intrarenal gradient characteristics of drugs provide us with a better understanding of factors of importance in appropriate antibiotic selection for the treatment of renal infections. The investigations also contribute to a better understanding of the mechanisms of antibiotic-induced nephrotoxicity and the potential clinical management by which such nephrotoxicity can be avoided. Study of the multiple physiologic and pathophysiologic factors that influence drug concentrations within the kidney should continue to provide us with information of both therapeutic and toxicologic value.
在存在健康肾组织的情况下,氨基糖苷类药物在肾脏皮质的定量蓄积表现出重要差异。这些现象可能与临床毒性相关。近端肾小管重吸收途径似乎在产生高肾脏皮质药物浓度方面具有关键意义。似乎这种药物转运可被竞争性阻断。肾组织中严重疾病的存在显著影响抗生素的肾内分布特征,并与除强力霉素外所有药物的实质浓度降低相关。确定药物肾内梯度特征的研究使我们能更好地理解在选择合适抗生素治疗肾脏感染时的重要因素。这些研究也有助于更好地理解抗生素诱导的肾毒性机制以及避免此类肾毒性的潜在临床管理方法。对影响肾脏内药物浓度的多种生理和病理生理因素的研究应继续为我们提供具有治疗和毒理学价值的信息。